What is Biltmore Technologies?
Biltmore Technologies is a specialized provider of Pharma Analytics, operating a cloud-based Platform-as-a-Service designed for the Life Sciences industry. Their flagship product, My Vital Signs Rx, offers robust data management, business intelligence, and reporting capabilities aimed at improving strategic decision-making for life science organizations. The company also extends its offerings through consulting services and the development of custom white-label applications to support client sales and marketing initiatives, emphasizing a commitment to personalized service and accountability.
How much funding has Biltmore Technologies raised?
Biltmore Technologies has raised a total of $268K across 2 funding rounds:
Debt
$150K
Debt
$118K
Debt (2020): $150K with participation from PPP
Debt (2021): $118K led by PPP
What's next for Biltmore Technologies?
With the recent influx of capital from a major strategic investment, Biltmore Technologies is poised for accelerated growth and market penetration. This large-scale, late-stage funding suggests a focus on scaling operations, enhancing product development, and potentially expanding its market reach. The company's strategic direction will likely involve leveraging its advanced analytics platform to further empower life science clients in navigating industry complexities and driving innovation.
See full Biltmore Technologies company page
